Log in with your email address username.


[Comment] Long-acting technologies for infectious diseases in LMICs

Imagine a child in the Sahel protected from malaria for an entire season after just one injection of chemoprophylaxis. Or a woman at risk of HIV in Zambia taking a single capsule every 2 weeks that slowly releases an antiretroviral drug to protect her from infection. Could the risk of resistance to medications for infectious diseases be reduced through the use of long-acting (LA) patches, implants, or injectable drugs?